Humacyte Inc
NASDAQ:HUMA
Humacyte Inc
NASDAQ:HUMA
Price:
0.7784
USD
-5.42%
Market Closed
Market Cap:
$150.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Humacyte Inc
NASDAQ:HUMA
|
US |
|
Sunil Healthcare Ltd
BSE:537253
|
IN |
|
T
|
Telus International Cda Inc
NYSE:TIXT
|
CA |
|
Opthea Ltd
ASX:OPT
|
AU |
|
Gyldendal ASA
OSE:GYL
|
NO |
|
Beetaloo Energy Australia Ltd
ASX:BTL
|
AU |
|
T
|
TriState Capital Holdings Inc
F:3ZS
|
US |
|
D
|
Danang Housing Investment Development JSC
VN:NDN
|
VN |
|
Moody's Corp
NYSE:MCO
|
US |
Cash Flow Statement
Cash Flow Statement
Humacyte Inc
Humacyte Inc
Currency: USD
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(87)
|
(71)
|
(85)
|
(26)
|
(26)
|
28
|
34
|
(12)
|
(29)
|
(89)
|
(89)
|
(111)
|
(106)
|
(140)
|
(153)
|
(149)
|
(78)
|
(59)
|
(37)
|
|
| Depreciation & Amortization |
10
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
|
| Stock-Based Compensation |
7
|
10
|
11
|
10
|
9
|
8
|
7
|
6
|
6
|
7
|
7
|
7
|
6
|
6
|
6
|
6
|
7
|
8
|
9
|
|
| Other Non-Cash Items |
8
|
5
|
3
|
(62)
|
(66)
|
(121)
|
(118)
|
(68)
|
(51)
|
6
|
7
|
23
|
14
|
42
|
49
|
43
|
(24)
|
(43)
|
(58)
|
|
| Cash Interest Paid |
0
|
0
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(1)
|
1
|
(1)
|
(1)
|
(1)
|
(3)
|
2
|
1
|
0
|
(2)
|
1
|
7
|
2
|
10
|
6
|
0
|
(5)
|
(10)
|
(18)
|
|
| Cash from Operating Activities |
(70)
N/A
|
(57)
+18%
|
(75)
-31%
|
(81)
-8%
|
(85)
-5%
|
(87)
-2%
|
(74)
+16%
|
(71)
+3%
|
(71)
+0%
|
(77)
-8%
|
(73)
+5%
|
(73)
0%
|
(82)
-11%
|
(81)
+1%
|
(91)
-12%
|
(98)
-8%
|
(100)
-2%
|
(104)
-4%
|
(105)
-1%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(1)
|
(2)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
(8)
|
0
|
(8)
|
(8)
|
6
|
0
|
8
|
8
|
2
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+60%
|
(0)
-58%
|
(8)
-4 226%
|
(8)
+0%
|
(8)
-1%
|
(8)
-1%
|
5
N/A
|
4
-23%
|
5
+47%
|
5
-5%
|
(0)
N/A
|
1
N/A
|
(1)
N/A
|
(2)
-36%
|
(2)
+5%
|
(1)
+10%
|
(2)
-27%
|
(1)
+49%
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
1
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
43
|
44
|
46
|
97
|
102
|
104
|
108
|
|
| Net Issuance of Debt |
21
|
18
|
260
|
270
|
251
|
251
|
8
|
(2)
|
(2)
|
(34)
|
(34)
|
(34)
|
(34)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(53)
|
|
| Other |
(0)
|
(1)
|
(1)
|
(4)
|
(4)
|
(3)
|
(3)
|
0
|
0
|
38
|
38
|
38
|
58
|
19
|
19
|
19
|
(1)
|
0
|
0
|
|
| Cash from Financing Activities |
21
N/A
|
18
-17%
|
260
+1 373%
|
267
+3%
|
247
-7%
|
248
+0%
|
5
-98%
|
(1)
N/A
|
(1)
+3%
|
5
N/A
|
5
-10%
|
5
-2%
|
68
+1 407%
|
61
-10%
|
63
+3%
|
114
+82%
|
98
-14%
|
101
+3%
|
55
-45%
|
|
| Change in Cash | ||||||||||||||||||||
| Net Change in Cash |
(49)
N/A
|
(40)
+19%
|
185
N/A
|
178
-4%
|
154
-14%
|
152
-1%
|
(77)
N/A
|
(68)
+12%
|
(69)
-1%
|
(66)
+3%
|
(63)
+5%
|
(69)
-9%
|
(13)
+81%
|
(21)
-63%
|
(30)
-40%
|
14
N/A
|
(3)
N/A
|
(5)
-51%
|
(50)
-943%
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(70)
N/A
|
(57)
+19%
|
(75)
-31%
|
(81)
-8%
|
(86)
-5%
|
(88)
-2%
|
(74)
+16%
|
(72)
+2%
|
(73)
-1%
|
(80)
-9%
|
(76)
+4%
|
(76)
+1%
|
(83)
-10%
|
(82)
+1%
|
(93)
-13%
|
(100)
-8%
|
(101)
-1%
|
(106)
-5%
|
(106)
0%
|
|
Switch to:
Switch to:
See Also
Discover More
